These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6198082)

  • 1. Drug resistance in cancer.
    Curt GA; Clendeninn NJ; Chabner BA
    Cancer Treat Rep; 1984 Jan; 68(1):87-99. PubMed ID: 6198082
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of DNA repair in cells treated with a combination of alkylating agents.
    Frankfurt OS; Seckinger D; Sugarbaker EV
    Anticancer Res; 1993; 13(4):947-52. PubMed ID: 8352564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor-biology basis of cancer chemotherapy].
    Saul G; Wolf G; Rose H
    Z Arztl Fortbild (Jena); 1981 May; 75(9):404-9. PubMed ID: 7281789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular mechanisms of the occurrence of tumor drug resistance and ways to overcome it].
    Belousova AK
    Vopr Onkol; 1978; 24(5):92-104. PubMed ID: 351956
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropsychiatric effects of chemotherapeutic agents for cancer.
    Peterson LG; Popkin MK
    Psychosomatics; 1980 Feb; 21(2):141-53. PubMed ID: 7360862
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of cardiac subacute toxicity of epirubicin, chlorambucil, cisplatin, methotrexate and a homo-aza-steroid ester with antitumor activity in rats using serum biochemical parameters.
    Pispirigos K; Paradelis AG; Karakiulakis G
    Arzneimittelforschung; 1997 Jan; 47(1):92-6. PubMed ID: 9037452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic drugs: clinical pharmacology and therapeutic use.
    Bender RA; Zwelling LA; Doroshow JH; Locker GY; Hande KR; Murinson DS; Cohen M; Myers CE; Chabner BA
    Drugs; 1978 Jul; 16(1):46-87. PubMed ID: 78795
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimetabolites.
    Grem JL; Chabner BA; Chu E; Johnson P; Yeh GC; Allegra CJ
    Cancer Chemother Biol Response Modif; 1991; 12():1-25. PubMed ID: 1834143
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkylating agents.
    Connors TA
    Cancer Chemother Biol Response Modif; 1992; 13():31-44. PubMed ID: 1389913
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinogenicity of alkylating cytostatic drugs in animals.
    Berger MR
    IARC Sci Publ; 1986; (78):161-76. PubMed ID: 3583389
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary complications caused by cytostatic drugs].
    Bruntsch U
    MMW Munch Med Wochenschr; 1980 Sep; 122(37):1260-1. PubMed ID: 6158682
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
    Shen D; Pastan I; Gottesman MM
    Cancer Res; 1998 Jan; 58(2):268-75. PubMed ID: 9443404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene amplification, drug resistance, and cancer.
    Schimke RT
    Cancer Res; 1984 May; 44(5):1735-42. PubMed ID: 6713376
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.
    Adjei AA; Budihardjo II; Rowinsky EK; Kottke TJ; Svingen PA; Buckwalter CA; Grochow LB; Donehower RC; Kaufmann SH
    Clin Cancer Res; 1997 May; 3(5):761-70. PubMed ID: 9815747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antineoplastic agents].
    Saito T
    Naika; 1971 Oct; 28(4):665-71. PubMed ID: 4943165
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of cancer of the gut.
    Matthias JQ
    Practitioner; 1971 Jan; 206(231):121-8. PubMed ID: 5540187
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukemia: experimental and preclinical studies.
    Capizzi RL
    Curr Opin Oncol; 1990 Feb; 2(1):10-7. PubMed ID: 2095215
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequence-dependent synergism between dichloromethotrexate and 5-fluorouracil in a human colon carcinoma cell line.
    Sobrero AF; Bertino JR
    Cancer Res; 1983 Sep; 43(9):4011-13. PubMed ID: 6871843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of toxicities induced by chemotherapy in breast cancer patients.
    Mehreen L; Khanam A
    Biomed Pharmacother; 2005 Oct; 59(9):524-7. PubMed ID: 16154313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.